Epigral Limited

rs. 2

any promise to update/provide such presentation along with results to be declared in the coming years. 2 | MEGHMANI FINECHEM LIMITED Company Overview Founded: 2007 Employees: 900+ 30% 22%

30%

ears. 2 | MEGHMANI FINECHEM LIMITED Company Overview Founded: 2007 Employees: 900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (F

22%

2 | MEGHMANI FINECHEM LIMITED Company Overview Founded: 2007 Employees: 900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (FY23)

0.8x

ed: 2007 Employees: 900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (FY23) ROCE (FY23) Capacity: Chlor-Alkali# – 421 KTPA Derivatives#

32%

07 Employees: 900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (FY23) ROCE (FY23) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190

9%

GHMANI FINECHEM LIMITED FY23 - Key Highlights FY23 Operational Highlights: o Volume growth of 9%, partially led by new product CPVC Resin and Epichlorohydrin and partially by growth in volume of C

93%

olume of Caustic Soda and Hydrogen Peroxide o Capacity utilization of Hydrogen Peroxide reached 93% and CMS reached 104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen

104%

oda and Hydrogen Peroxide o Capacity utilization of Hydrogen Peroxide reached 93% and CMS reached 104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen Peroxide was up 5%

24%

ation of Hydrogen Peroxide reached 93% and CMS reached 104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen Peroxide was up 5% FY23 Financial Highlights: o Revenue from

11%

oxide reached 93% and CMS reached 104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen Peroxide was up 5% FY23 Financial Highlights: o Revenue from operations grew 41% t

5%

104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen Peroxide was up 5% FY23 Financial Highlights: o Revenue from operations grew 41% to ₹ 2,188 Cr on account of highe

41%

y 11% and Hydrogen Peroxide was up 5% FY23 Financial Highlights: o Revenue from operations grew 41% to ₹ 2,188 Cr on account of higher realization compared to last year and volume growth from exist

“900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (FY23) ROCE (FY23) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190 KTPA Revenue from operations (₹ Cr) 5,000”

“Further expansions that we are currently working in FY24 will drive growth for FY25.”

Founded

1

Employees

1

Certified

1

Manufacturing facility

1

Employees

900+ 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) 0.8x 32% Net Debt to Equity (FY23) ROCE (FY23) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190 KTPA Revenue from operations (₹ Cr) 5,000

Manufacturing facility

Fully integrated and automated complex FY19 FY18 FY21 FY22 FY23 FY27E # Chlor-Alkali : Caustic Soda - 400 KTPA and Caustic Potash - 21 KTPA Derivatives : CPVC Resin – 30 KTPA, Epichlorohydrin – 50 KTPA, Chloromethane - 50 KTPA and Hydrogen Peroxide - 60 KTPA 3 | MEGHMANI FINECHEM LIMITED FY23 - Key Highlights FY23 Operational Highlights: o Volume growth of 9%, partially led by new product CPVC Resin and Epichlorohydrin and partially by growth in volume of Caustic Soda and Hydrogen Peroxide o Capacity utilization of Hydrogen Peroxide reached 93% and CMS reached 104% o Realization - Caustic Soda was up by 24%, CMS was down by 11% and Hydrogen Peroxide was up 5% FY23 Financial Highlights: o Revenue from operations grew 41% to ₹ 2,188 Cr on account of higher realization compared to last year and volume growth from existing products as well as new products o Revenue contribution from Derivatives & Specialty Chemical segment increased to 30% in FY23 vs 25% in FY22 o EBITDA grew 35% to ₹ 689